4HG0.F Qlife Holding AB (publ)

Healthcare Medical Devices Frankfurt Exchange
0.0644 EUR
Close of Nov 11, 2026
0.0591 0.2790
Market cap
EUR 1.86M
P/E
-
P/B
7.11x
ROE
-845.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 4HG0.F undervalued?

Graham number

The Graham number of Qlife Holding AB (publ) cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Qlife Holding AB (publ) fundamental analysis

No fundamental analysis for Qlife Holding AB (publ) yet.

Qlife Holding AB (publ) stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Qlife Holding AB (publ)

Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents in Sweden. The company offers Egoo.Health Platform, a product platform that enables advanced biomarker testing, consisting of a small device, disposable capsules, and the supplementing software. Qlife Holding AB (publ) was incorporated in 2019 and is based in Gothenburg, Sweden.

Full company profile